Found: 14
Select item for more details and to access through your institution.
Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00536-8
- By:
- Publication type:
- Article
Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0122387
- By:
- Publication type:
- Article
Broad T-Cell Receptor Repertoire in T-Lymphocytes Derived from Human Induced Pluripotent Stem Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0097335
- By:
- Publication type:
- Article
CMV-Independent Lysis of Glioblastoma by <i>Ex Vivo</i> Expanded/Activated Vδ1+ γδ T Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0068729
- By:
- Publication type:
- Article
Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0051805
- By:
- Publication type:
- Article
Characterization of the γδ T cell response to acute leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1072, doi. 10.1007/s00262-005-0094-6
- By:
- Publication type:
- Article
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2852, doi. 10.3390/cancers16162852
- By:
- Publication type:
- Article
Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092339
- By:
- Publication type:
- Article
Cytotoxic and Regulatory Properties of Circulating Vδ1+ γδ T Cells: A New Player on the Cell Therapy Field?
- Published in:
- Molecular Therapy, 2014, v. 22, n. 8, p. 1416, doi. 10.1038/mt.2014.104
- By:
- Publication type:
- Article
IMMU-15. ENGINEERED-DRUG RESISTANT GAMMA-DELTA (γδ) T CELLS COMBINED WITH IMMUNE CHECKPOINT BLOCKADE AUGMENTED KILLING OF CANCER CELLS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi124, doi. 10.1093/neuonc/noy148.518
- By:
- Publication type:
- Article
Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0166891
- By:
- Publication type:
- Article
Hematologic aspects of myeloablative therapy and bone marrow transplantation.
- Published in:
- Journal of Clinical Laboratory Analysis, 2005, v. 19, n. 2, p. 47, doi. 10.1002/jcla.20055
- By:
- Publication type:
- Article